Schedule 13D ownership disclosure
OUTLOOK THERAPEUTICS INC
Security class unavailable · CUSIP: 69012T206
Event date: 2024-01-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 16,637,024
- Percent of class
- 6.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-008778
- Form type
- SC 13D
- Filer
- Outlook Therapeutics, Inc.
- CIK
- CIK 1649989
- Filed
- Jan 31, 2024
- Reporting period
- Jan 25, 2024
- Description
- Schedule 13D beneficial ownership